Retinal oxidation, apoptosis and age- and sex-differences in the mnd mutant mouse, a model of neuronal ceroid lipofuscinosis

Brain Research

Volumn 1014, Issue 1-2, 2004, Pages 209-220

  Guarneri, Rosetta ^a   Russo, Domenica ^a   Cascio, Caterina ^a   D'Agostino, Stefania ^a   Galizzi, Giacoma ^a   Bigini, Paolo ^b   Mennini, Tiziana ^b   Guarneri, Patrizia ^a  

^a CNR Consiglio Nazionale delle Ricerche   (Italy)

^b Laboratory of Cancer Pharmacology   (Italy)

Author keywords

4 HNE adduct; Degenerative disease; Disorders of the nervous system; Lipid peroxide; Mnd mouse; Neuronal ceroid lipofuscinosis; Oxidative stress; Retinal degeneration; Superoxide dismutase

Indexed keywords

4 HYDROXYNONENAL; CASPASE 3; DNA FRAGMENT; FREE RADICAL; LIPID PEROXIDE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; FRAGMENTATION REACTION; GENE MUTATION; GENETIC VARIABILITY; HISTOPATHOLOGY; NERVE CELL; NEURONAL CEROID LIPOFUSCINOSIS; NICK END LABELING; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RETINOPATHY; SEX DIFFERENCE; STAINING; STATISTICAL ANALYSIS;

ALDEHYDES; ANIMALS; APOPTOSIS; CASPASE 3; CASPASES; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; FEMALE; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; MICE; MICE, INBRED C57BL; MICE, NEUROLOGIC MUTANTS; NEURONAL CEROID-LIPOFUSCINOSES; OXIDATION-REDUCTION; OXIDATIVE STRESS; RETINA; RETINAL DEGENERATION; SEX FACTORS; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 2942699883     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2004.04.040     Document Type: Article

References (66)

1. Aguirre G.D., Ray J., Stramm L.E. Diseases of retinal pigment epithelium-photoreceptor complex in non-rodent animal models. Marmor M.F., Wolfensberger T.J. The Retinal Pigment Epithelium: Function and Disease. 1998;247-306 Oxford Univ. Press, New York. Chap. 14
2. Avezedo R.B., Lacava Z.G.M., Miyasaka C.K., Chaves S.B., Curi R. Regulation of antioxidant enzyme activities in male and female rat macrophages by sex steroids. Braz. J. Med. Biol. Res. 34:2001;683-687
3. Bensaoula T., Shibuya H., Katz M.L., Smith J.E., Johnson G.S., John S.K., Milam A.H. Histopathologic and immunocytochemical analysis of the retina and ocular tissues in Batten disease. Ophthalmology. 107:2000;1746-1753
4. Bertamini M., Marzani B., Guarneri R., Guarneri P., Bigini P., Mennini T., Curti D. Mitochondrial oxidative metabolism in motor neuron degeneration (mnd) mouse central nervous system. Eur. J. Neurosci. 16:2002;2291-2296
5. Bolivar V.J., Scott Ganus J., Messer A. The development of behavioral abnormalities in the motor neuron degeneration (mnd) mouse. Brain Res. 937:2002;74-82
6. Boulton M. Ageing of the retinal pigment epithelium. Osborne N., Chader G. Progress in Retina Research. 1991;125-151 Pergamon, London
7. Bronson R.T., Donahue L.R., Johnson K.R., Tanner A., Lane P.W., Faust J.R. Neuronal ceroid lipofuscinosis (nclf), a new disorder of the mouse linked to chromosome 9. Am. J. Med. Genet. 77:1998;289-297
8. Butterfield R.J., Roper R.J., Rhein D.M., Melvold R.W., Haynes L., Ma R.Z., Doerge R.W., Teuscher C. Sex-specific quantitative trait loci govern susceptibility to Theiler's murine encephalomyelitis virus-induced demyelination. Genetics. 163:2003;1041-1046
9. Carrillo M.C., Kanai S., Sato Y., Kitani K. Age-related changes in antioxidant enzyme activities are region and organ, as well as sex, selective in the rat. Mech. Ageing Dev. 65:1992;187-198
10. Cascio C., Guarneri R., Russo D., De Leo G., Guarneri M., Piccoli F., Guarneri P. Pregnenolone sulfate, a naturally-occurring excitotoxin involved in delayed retinal cell death. J. Neurochem. 74:2000;2380-2391
11. Cascio C., Guarneri R., Russo D., De Leo G., Guarneri M., Piccoli F., Guarneri P. A caspase-3-dependent pathway is predominantly activated by the excitotoxin pregnenolone sulphate and requires early and late cytochrome c release and cell-specific caspase-2 activation in the retinal cell death. J. Neurochem. 83:2002;1-14
12. Cideciyan A.V., Aleman T.S., Swider M., Schwartz S.B., Steinberg J.D., Brucker A.J., Maguire A.M., Bennett J., Stone E.M., Jacobson S.G. Mutations in ABCA4 result in accumulation of lipofuscin before slowing of the retinoid cycle: a reappraisal of the human disease sequence. Hum. Mol. Genet. 13:2004;525-534
13. Cooper J.D. Progress towards understanding the neurobiology of Batten disease or neuronal ceroid lipofuscinosis. Curr. Opin. Neurol. 16:2003;121-128
14. Dawson G., Cho S. Batten's disease: clues to neuronal protein catabolism in lysosomes. J. Neurosci. Res. 60:2000;133-140
15. Dawson G., Kilkus J., Siakotos A.N., Singh I. Mitochondrial abnormalities in CLN2 and CLN3 forms of Batten disease. Mol. Chem. Neuropathol. 29:1996;227-235
16. Elleder M. Neuronal ceroid lipofuscinosis. Closing chapter of a long story. Cesk. Patol. 36:2000;43-59
17. Esterbauer H., Schaur R.J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes. Free Radic. Biol. Med. 11:1992;81-128
18. Floyd R.A., Hensley K. Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases. Neurobiol. Aging. 23:2002;795-807
19. Fujita K., Shibayama K., Yamauchi M., Kato T., Ando M., Takahashi H., Iritani K., Yoshimoto N., Nagata Y. Alteration of enzymatic activities implicating neuronal degeneration in the spinal cord of the motor neuron degeneration mouse during postnatal development. Neurochem. Res. 23:1998;557-562
20. Garg H.S., Awasthi Y.C., Neff W.A., Ansari N.H., Srivastava S.K. Studies in neuronal ceroid lipofuscinosis: enzymes of liver and brain tissues involved in the defense against oxidative damage. J. Neurosci. Res. 7:1982;305-311
21. Goebel H.H. Retina in various animal models of neuronal ceroid-lipofuscinosis. Am. J. Med. Genet. 42:1992;605-608
22. Goebel H.H. Morphologic diagnosis in neuronal ceroid lipofuscinosis. Neuropediatrics. 28:1997;167-169
23. Griffin J.L., Muller D., Woograsingh R., Jowatt V., Hindmarsh A., Nicholson J.K., Martin J.E. Vitamin E deficiency and metabolic deficits in neuronal ceroid lipofuscinosis described by bioinformatics. Physiol. Genomics. 11:2002;195-203
24. Haltia M., Tyynela J., Hirvasniemi A., Herva R., Ranta U.S., Lehesjoki A.-E. CLN8: northern epilepsy. Goebel H.H., Mole S.E., Lake B.D. The Neuronal Ceroid Lipofuscinoses (Batten Disease). 1999;117-124 IOS Press, Amsterdam
25. Hamilton M.L., Van Remmen H., Drake J.A., Yang H., Guo Z.M., Kewitt K., Walter C.A., Richardson A. Does oxidative damage to DNA increase with age? Proc. Natl. Acad. Sci. U. S. A. 98:2001;10469-10474
26. Hayward L.M., Burden M.L., Burden A.C., Blackledge H., Raymond N.T., Botha J.L., Karwatowski W.S., Duke T., Chang Y.F. What is the prevalence of visual impairment in the general and diabetic populations: are there ethnic and gender differences? Diabet. Med. 19:2002;27-34
27. Heine C., Tyynelä J., Cooper J.D., Palmer D.N., Elleder M., Kohlschütter A., Braulke T. Enhanced expression of manganese-dependent superoxide dismutase in human and ovine CLN6 tissues. Biochem. J. 376:2003;369-376
28. Hornstein E.P., O'Carroll D.C., Anderson J.C., Laughlin S.B. Sexual dimorphism matches photoreceptor performance to behavioural requirements. Proc. R. Soc. Lond., B Biol. Sci. 267:2000;2111-2117
29. Huber A. Genetic diseases of vision. Curr. Opin. Neurol. 7:1994;65-68
30. Jarvela I., Glueck S.B. Charting the effects of antioxidant therapy in the diseased brain: focus on "vitamin E deficiency and metabolic deficits in neuronal ceroid lipofuscinosis described by bioinformatics" Physiol. Genomics. 11:2002;183-184
31. Jolly R.D., Brown S., Das A.M., Walkley S.U. Mitochondrial dysfunction in the neuronal ceroid-lipofuscinoses (Batten disease). Neurochem. Int. 40:2002;565-571
32. Jomary C., Neal M.J., Jones S.E. Characterization of cell death pathways in murine retinal neurodegeneration implicates cytochrome c release, caspase activation, and bid cleavage. Mol. Cell. Neurosci. 18:2001;335-346
33. Kakela R., Somerharju P., Tyynela J. Analysis of phospholipid molecular species in brains from patients with infantile and juvenile neuronal-ceroid lipofuscinosis using liquid chromatography-electrospray ionization mass spectrometry. J. Neurochem. 84:2003;1051-1065
34. Katz M.L., Rice L.M., Gao C. Dietary carnitine supplements slow disease progression in a putative mouse model for hereditary ceroid-lipofuscinosis. J. Neurosci. Res. 57:1997;551-556
35. Kieseier B.C., Wisniewski K.E., Schuller-Lewis G., Park E., Goebel H.H. Normal superoxide radical production in the neuronal ceroid-lipofuscinosis. Neuropediatrics. 27:1996;202-203
36. Koike M., Shibata M., Ohsawa Y., Nakanishi H., Koga T., Kametaka S., Waguri S., Momoi T., Kominami E., Peters C., von Figura K., Safting P., Uchiyama Y. Involvement of two different cell death pathways in retinal atrophy of cathepsin D-deficient mice. Mol. Cell. Neurosci. 22:2003;146-161
37. Lane S.C., Jolly R.D., Schmechel D.E., Alroy J., Boustany R.M. Apoptosis as the mechanism of neurodegeneration in Batten's disease. J. Neurochem. 67:1996;677-683
38. Lev S. Molecular aspects of retinal degenerative diseases. Cell. Mol. Neurobiol. 2:2001;575-589
39. Marklund S.L., Santavuori P., Westermarck T. Superoxide dismutase, catalase and glutathione peroxidase in infantile, late-infantile and juvenile neuronal ceroid-lipofuscinosis. Clin. Chim. Acta. 116:1981;191-198
40. Mennini T., Bastone A., Crespi D., Comoletti D., Manzoni C. Spinal cord GLT-1 glutamate transporter and blood glutamic acid alterations in motor neuron degeneration (Mnd) mice. J. Neurol. Sci. 157:1998;31-36
41. Mennini T., Bigini P., Cagnotto A., Carvelli L., Di Nunno P., Fumagalli E., Tortarolo M., Buurman W.A., Grezzi P., Bendotti C. Glial activation and TNFR-I upregulation precedes motor dysfunction in the spinal cord of mnd mice. Cytokines. 25:2004;127-135
42. Messer A., Plummer J., Maskin P., Coffin J.M., Frankel W.N. Mapping of the motor neuron degeneration (Mnd) gene, a mouse model of amyotrophic lateral sclerosis (ALS). Genomics. 18:1992;797-802
43. Messer A., Plummer J., Wong V., La Vail M.M. Retinal degeneration in motor neuron degeneration (mnd) mutant mice. Exp. Eye Res. 57:1993;637-641
44. Messer A., Plummer J., MacMillen M.C., Frankel W.N. Genetics of primary and timing effects in the mnd mouse. Am. J. Med. Genet. 57:1995;361-364
45. Messer A., Manley K., Plummer J.A. An early-onset congenic strain of the motor neuron degeneration (mnd) mouse. Mol. Genet. Metab. 66:1999;393-397
46. Munroe P.B., Mitchison H.M., O'Rawe A.M., Anderson J.W., Boustany R.M., Lerner T.J., Taschner P.E., de Vos N., Breuning M.H., Gardiner R.M., Mole S.E. Spectrum of mutations in the Batten disease gene. Am. J. Hum. Genet. 61:1997;310-316
47. Ogueta S.B., Schwartz S.D., Yamashita C.K., Farber D.B. Estrogen receptor in the human eye: influence of gender and age on gene expression. Invest. Ophthalmol. Visual Sci. 40:1999;1906-1911
48. Pardo C.A., Rabin B.A., Palmer D.N., Price D.L. Accumulation of the adenosine triphosphate synthase subunit C in the mnd mutant mouse. Am. J. Pathol. 144:1994;829-835
49. Pigeolet E., Corbisier P., Houbion A., Lambert D., Michiels C., Raes M., Zaxhary M.D., Remacle J. Glutathione peroxidase, superoxide dismutase and catalase inactivation by peroxides and oxygen derived free radicals. Mech. Ageing Dev. 51:1990;283-297
50. Puranam K.L., Guo W.-X., Qian W.-H., Nikbakht K., Boustany R.-S. CLN3 defines a novel antiapoptotic pathway operative in neurodegeneration and mediated by ceramide. Mol. Genet. Metab. 66:1999;294-308
51. Ranta S., Zhang Y., Ross B., Lonka L., Takkunen E., Messer A., Sharp J., Wheeler R., Kusumi K., Mole S., Liu W., Soares M.B., Bonaldo M.F., Hirvasniemi A., de la Chapelle A., Gilliam T.C., Lehesjoki A.E. The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8. Nat. Genet. 23:1999;233-236
52. Rao A.V., Balachandran B. Role of oxidative stress and antioxidants in neurodegenerative diseases. Nutr. Neurosci. 5:2002;291-309
53. Santavuori P., Heiskala H., Westermarck T., Sainio K., Moren R. Experience over 17 years with antioxidant treatment in Spielmeyer-Sjogren disease. Am. J. Med. Genet., Suppl. 5:1988;265-274
54. Schmidt S., Klaver C., Saunders A., Postel E., De La Paz M., Agarwal A., Small K., Udar N., Ong J., Chalukya M., Nesburn A., Kenney C., Domurath R., Hogan M., Mah T., Conley Y., Ferrell R., Weeks D., de Jong P.T., van Duijn C., Haines J., Pericak-Vance M., Gorin M. A pooled case-control study of the apolipoprotein E (APOE) gene in age-related maculopathy. Ophthalmic Genet. 23:2002;209-223
55. Seki S., Kitada T., Sakaguchi H., Nakatani K., Wakasa K. Pathological significance of oxidative cellular damage in human alcoholic liver disease. Histopathology. 42:2003;365-371
56. Siakotos A.N., Bray R., Dratz E., van Kuijk F., Sevaninan A., Koppang N. 4-Hydroxynonenal: a specific indicator for canine neuronal-retinal ceroidosis. Am. J. Genet., Suppl. 5:1988;171-181
57. Simon H.U., Haj-Heyia A., Levi-Schaffer F. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis. 5:2000;415-418
58. Sobocanec S., Balog T., Sverko V., Marotti T. Sex-dependent antioxidant enzyme activities and lipid peroxidation in ageing mouse brain. Free Radic. Res. 37:2003;743-748
59. Stein D.G. Brain damage, sex hormones and recovery: a new role for progesterone and estrogen? Trends Neurosci. 24:2001;386-391
60. Strehlow K., Rotter S., Wassmann S., Adam O., Grohe C., Laufs K., Bohm M., Nickening G. Modulation of antioxidant enzyme expression and function by estrogen. Circ. Res. 93:2003;170-177
61. Swaab D.F., Chung W.C., Kruijver F.P., Hofman M.A., Hestiantoro A. Sex differences in the hypothalamus in the different stages of human life. Neurobiol. Aging. 24(Suppl. 1):2003;S1-S16
62. Tang D.G., La E., Kern J., Kehrer J.P. Fatty acid oxidation and signaling in apoptosis. Biol. Chem. 383:2002;425-442
63. Vance J.E., Stone S.J., Faust J.R. Abnormalities in mitochondria- associated membranes and phospholipid biosynthetic enzymes in the mnd/mnd mouse model of neuronal ceroid lipofuscinosis. Biochim. Biophys. Acta. 1344:1997;286-299
64. Weleber R.G. The dystrophic retina in multisystem disorders: the electroretinogram in neuronal ceroid lipofuscinoses. Eye. 12:1998;580-590
65. Whitacre C.C., Reingold S.C., O'Looney P.A. A gender gap in autoimmunity. Science. 283:1999;1277-1278
66. Zhong N. Neuronal ceroid lipofuscinoses and possible pathogenic mechanism. Mol. Genet. Metab. 71:2000;195-206